NCT00895297 Efficacy and Safety Study of Dasatinib in Patients With Chronic Myeloid Leukemia Status TERMINATED Phase PHASE2
NCT00890890 A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease Status TERMINATED Phase PHASE2
NCT00886795 Safety and Efficacy of Abatacept in Subjects With Chronic Urticaria Who Have Had an Inadequate Response to Anti-histamine Therapy Status COMPLETED Phase PHASE1/PHASE2
NCT00886782 A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT00884676 Ixabepilone and Sunitinib Malate in Treating Patients With Progressive Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00884546 Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma Status COMPLETED Phase PHASE1
NCT00882583 A Study of Dasatinib, Cetuximab and Radiation With or Without Cisplatin in HNSCC Status TERMINATED Phase PHASE1
NCT00874770 Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care (Pegylated-interferon Alpha and Ribavirin) Status COMPLETED Phase PHASE2
NCT00872976 Study of Dasatinib and Bendamustine in Chronic Lymphocytic Leukemia Status WITHDRAWN Phase PHASE1
NCT00870727 Study of Aripiprazole in the Treatment of Pervasive Developmental Disorders Status COMPLETED Phase PHASE3
NCT00869401 Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Status COMPLETED Phase PHASE1/PHASE2
NCT00866905 Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer Status COMPLETED Phase PHASE2
NCT00862823 The Bioequivalence of Atripla in an Oral Liquid Formulation Compared With the Tablet Formulation in Healthy Volunteers Status COMPLETED Phase PHASE4
NCT00860158 Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer Status TERMINATED Phase PHASE2